Moody’s affirms Milford Regional Medical Center’s ‘Baa3’ rating

Moody’s Investors Service has affirmed the “Baa3” rating on Milford (Mass.) Regional Medical Center’s outstanding revenue bonds.

Advertisement

The rating affirmation is based on several factors, including MRMC’s stable market position, solid liquidity coverage and conservative debt structure.

Offsetting these strengths are MRMC’s small size and thinning cash flow.

The outlook is stable, reflecting Moody’s Investors Service’s expectations of slowly improving cash flow and gradual improvement of liquidity.

More articles on healthcare finance:
UnitedHealth to exit 2 state ACA exchanges: 5 things to know
South Dakota hospital set to lose Medicare status
Troubled Calhoun Liberty Hospital seeks donations: 6 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.